Nitric oxide in tumour biology and cancer therapy. Part 1: Physiological aspects (Q41642253)

6 October 2017

1 reference

title

Nitric oxide in tumour biology and cancer therapy. Part 1: Physiological aspects (English)

1 reference

6 October 2017

Tozer GM

1

1 reference

6 October 2017

Everett SA

series ordinal

2

1 reference

6 October 2017

publication date

1 January 1997

1 reference

6 October 2017

1 reference

6 October 2017

volume

9

1 reference

6 October 2017

issue

5

1 reference

6 October 2017

page(s)

282-293

1 reference

Nitric oxide: mediator, murderer, and medicine

6 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980061-5

7 January 2021

The arginine-nitric oxide pathway: a target for new drugs.

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980061-5

7 January 2021

Nitric oxide: a new paradigm for second messengers.

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980061-5

7 January 2021

Nitric oxide-based possibilities for pharmacotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980061-5

7 January 2021

Nitric oxide and cardiac function.

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980061-5

7 January 2021

Molecular mechanisms and therapeutic strategies related to nitric oxide.

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980061-5

7 January 2021

Nitric oxide and anti-cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980061-5

7 January 2021

Nitric oxide synthases: Roles, tolls, and controls

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980061-5

7 January 2021

Substrate binding and calmodulin binding to endothelial nitric oxide synthase coregulate its enzymatic activity

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980061-5

7 January 2021

A tutorial on the diffusibility and reactivity of free nitric oxide.

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980061-5

7 January 2021

A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980061-5

7 January 2021

NO, nitrosonium ions, nitroxide ions, nitrosothiols and iron-nitrosyls in biology: a chemist's perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980061-5

7 January 2021

Redox signaling: nitrosylation and related target interactions of nitric oxide

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980061-5

7 January 2021

Approaches toward selective inhibition of nitric oxide synthase

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980061-5

7 January 2021

Selective pharmacological inhibition of distinct nitric oxide synthase isoforms

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980061-5

7 January 2021

Induction of nitric oxide synthase in the neo-vasculature of experimental tumours in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980061-5

7 January 2021

Nitric oxide synthase activity in human breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980061-5

7 January 2021

Nitric oxide synthase activity and expression in human colorectal cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980061-5

7 January 2021

Excessive production of nitric oxide in rat solid tumor and its implication in rapid tumor growth.

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980061-5

7 January 2021

Temporal heterogeneity in microregional erythrocyte flux in experimental solid tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980061-5

7 January 2021

Intracapillary oxyhemoglobin saturation of malignant tumors in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980061-5

7 January 2021

Nitric oxide is a mediator of hypoxic coronary vasodilatation. Relation to adenosine and cyclooxygenase-derived metabolites

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980061-5

7 January 2021

Endothelium-derived nitric oxide regulates systemic and pulmonary vascular resistance during acute hypoxia in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980061-5

7 January 2021

Evidence nitric oxide mediates the vasodepressor response to hypoxia in sino-denervated rats

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980061-5

7 January 2021

Interaction of nitric oxide and cyclic guanosine 3',5'-monophosphate in erythropoietin production

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980061-5

7 January 2021

Nitric oxide enhancement of erythropoietin production in the isolated perfused rat kidney

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980061-5

7 January 2021

Increased gene expression for VEGF and the VEGF receptors KDR/Flk and Flt in lungs exposed to acute or to chronic hypoxia. Modulation of gene expression by nitric oxide

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980061-5

7 January 2021

A hypoxia-responsive element mediates a novel pathway of activation of the inducible nitric oxide synthase promoter

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980061-5

7 January 2021

Regulation of endothelial nitric-oxide synthase during hypoxia.

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980061-5

7 January 2021

Regulation of bovine endothelial constitutive nitric oxide synthase by oxygen

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980061-5

7 January 2021

Hypoxia decreases constitutive nitric oxide synthase transcript and protein in cultured endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980061-5

7 January 2021

Prolonged in vivo hypoxia enhances nitric oxide synthase type I and type III gene expression in adult rat lung

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980061-5

7 January 2021

Oxygen tension regulates the nitric oxide pathway. Physiological role in penile erection

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980061-5

7 January 2021

Nitric oxide binding to the heme of neuronal nitric-oxide synthase links its activity to changes in oxygen tension

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980061-5

7 January 2021

Signalling by cGMP-dependent protein kinases

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980061-5

7 January 2021

The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980061-5

7 January 2021

Endothelium-derived relaxing factor from pulmonary artery and vein possesses pharmacologic and chemical properties identical to those of nitric oxide radical

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980061-5

7 January 2021

Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980061-5

7 January 2021

Interaction between endothelin-1 and endothelium-derived relaxing factor in human arteries and veins

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980061-5

7 January 2021

Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980061-5

7 January 2021

Cardiac and regional haemodynamics, inducible nitric oxide synthase (NOS) activity, and the effects of NOS inhibitors in conscious, endotoxaemic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980061-5

7 January 2021

Hypertension in mice lacking the gene for endothelial nitric oxide synthase

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980061-5

7 January 2021

Vascular endothelium: vasoactive mediators

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980061-5

7 January 2021

Shear Stress Dependent Regulation of Vascular Resistance in Health and Disease: Role of Endothelium

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980061-5

7 January 2021

S-nitrosohaemoglobin: a dynamic activity of blood involved in vascular control

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980061-5

7 January 2021

Endothelium-dependent inhibition of platelet aggregation

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980061-5

7 January 2021

Endothelium-derived relaxing factor inhibits in vitro platelet aggregation

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980061-5

7 January 2021

The anti-aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980061-5

7 January 2021

Comparative pharmacology of endothelium-derived relaxing factor, nitric oxide and prostacyclin in platelets

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980061-5

7 January 2021

Effects of nitric oxide-containing compounds on increases in cytosolic ionized Ca2+ and on aggregation of human platelets

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980061-5

7 January 2021

Endothelium-derived relaxing factor modulates platelet aggregation in an in vivo model of recurrent platelet activation

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980061-5

7 January 2021

Endogenous nitric oxide protects against platelet aggregation and cyclic flow variations in stenosed and endothelium-injured arteries

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980061-5

7 January 2021

Nitric oxide and cardiovascular control

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980061-5

7 January 2021

Effect of common agonists on cytoplasmic ionized calcium concentration in platelets. Measurement with 2-methyl-6-methoxy 8-nitroquinoline (quin2) and aequorin

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980061-5

7 January 2021

Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980061-5

7 January 2021

The role of nitric oxide and cGMP in platelet adhesion to vascular endothelium

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980061-5

7 January 2021

Endothelium-derived relaxing factor inhibits platelet adhesion to cultured porcine endocardial endothelium

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980061-5

7 January 2021

Nitric oxide functions as an inhibitor of platelet adhesion under flow conditions

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980061-5

7 January 2021

Nitric oxide reduces endothelial expression of intercellular adhesion molecule (ICAM)-1

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980061-5

7 January 2021

Modification of Tumour Blood Flow—a Review

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980061-5

7 January 2021

Inhibitors of nitric oxide synthase selectively reduce flow in tumor-associated neovasculature

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980061-5

7 January 2021

Modification of energy metabolism and radiation response of a murine tumour by changes in nitric oxide availability.

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980061-5

7 January 2021

Modification of metabolism of transplantable and spontaneous murine tumors by the nitric oxide synthase inhibitor, nitro-L-arginine.

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980061-5

7 January 2021

Nitric oxide synthase inhibition irreversibly decreases perfusion in the R3230Ac rat mammary adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980061-5

7 January 2021

Stroma-free human hemoglobin A decreases R3230Ac rat mammary adenocarcinoma blood flow and oxygen partial pressure

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980061-5

7 January 2021

Enhanced vascular permeability in solid tumor is mediated by nitric oxide and inhibited by both new nitric oxide scavenger and nitric oxide synthase inhibitor.

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980061-5

7 January 2021

Therapeutic effects of imidazolineoxyl N-oxide against endotoxin shock through its direct nitric oxide-scavenging activity

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980061-5

7 January 2021

Angiogenesis in cancer, vascular, rheumatoid and other disease

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980061-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980061-5

1 reference

7 January 2021

Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P.

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980061-5

7 January 2021

Inhibition of nitric oxide synthase delays healing of chronic gastric ulcers

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980061-5

7 January 2021

Healing of chronic gastric ulcerations by L-arginine. Role of nitric oxide, prostaglandins, gastrin and polyamines

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980061-5

7 January 2021

Substance P and nitric oxide mediate would healing of ultraviolet photodamaged rat skin: evidence for an effect of nitric oxide on keratinocyte proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980061-5

7 January 2021

Exogenous nitric oxide inhibits proliferation of cultured vascular endothelial cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980061-5

7 January 2021

Nitric oxide inhibits migration of cultured endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980061-5

7 January 2021

Evidence that nitric oxide is an endogenous antiangiogenic mediator

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980061-5

7 January 2021

In vivo experimental evidence that the nitric oxide pathway is involved in the X-ray-induced antiangiogenicity

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980061-5

7 January 2021

Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980061-5

7 January 2021

Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980061-5

7 January 2021

Significance of vascular endothelial growth factor/vascular permeability factor for solid tumor growth, and its inhibition by the antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980061-5

7 January 2021

Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle.

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980061-5

7 January 2021

10.1016/S0936-6555(05)80061-5

Identifiers

DOI

1 reference

6 October 2017

1 reference